We’re looking across industries for the companies building the technology to adapt to and/or mitigate climate change. Together with our external climate partners and our in-house teams, we look to identify and support the visionaries with the greatest potential to make a difference.
Trove: case study
Trove is a market leader in branded recommerce, providing white-label software and end-to-end operations to brands in the retail, apparel, outdoor, and luxury segments. Trove enables premium brands to intake, aggregate, and authenticate preowned versions of their goods and then resell them to consumers.
Our investments
AMP Robotics
Founded in 2015 and headquartered in Louisville, CO. AMP Robotics offers recycling solutions pairing AI with innovative robotic technology to drive higher recycling levels while also solving critical pain points around labor shortages, processing costs, and global sustainability goals.
Arcadia
Arcadia is a climate crisis-fighting tech company unlocking access to data and clean energy sources.
AssetWatch
AssetWatch is a leading provider of predictive maintenance solutions for manufacturers, which uses proprietary sensors and software / AI to proactively manage machine health and help prevent unplanned downtime while delivering meaningful energy efficiency benefits.
Meati
Headquartered in Boulder, CO. Meati specializes in the production of fungi-based proteins that are healthier and more climate-friendly than traditional animal products. Meati is the first to market in the U.S. with a nutritious and clean-ingredient product that competes with whole-cut chicken and steak.
Orennia, Inc.
Founded in 2021 and headquartered in Calgary, Canada, Orennia is a data analytics platform that enables the build-out of renewable energy assets, accelerating the clean energy transition by providing critical project-level information and decreasing the time and cost to complete key investment analysis.
Span IO
Span manufactures and provides a connected, software-enabled home electrical panel, the main distribution point for electrical circuits within the home, and other smart paired devices such as an EV charger.
Trove
Founded in 2012 and headquartered in Brisbane, CA. Trove is the leading enterprise solution in the Recommerce space, providing major brands and retailers a comprehensive solution to offering re-sale in-house, allowing them to compete in a fast-growing resale space.
Wellington’s climate team is taking a deep dive and doing more than just providing us funds but providing actionable feedback.
Dr. Matanya Horowitz is the CEO and founder of AMP Robotics, which is a portfolio company that Wellington has invested in. This statement about Wellington reflects a personal opinion that may not be shared by others. There has been no compensation provided for such statements.
Meet the climate growth team
News
Forbes | Wellington Access Ventures Raises $150 Million To Back Underrepresented Founders
Our Wellington Access Ventures Team sat down with Forbes to discuss the final close of the private investing platform’s first early-stage venture capital fund and how they look to partner with "the next industry-defining companies."
Source: Forbes.
Wellington Management announces US$150 million final close for Wellington Venture Investments I
iCapital® and Wellington Management forge global partnership
iCapital® and Wellington Management Forge Global Partnership to Enhance Access to Institutional-Quality Alternative Investments
Insights
Governance best practices in public markets
For private companies approaching the public markets, we highlight the corporate governance best practices that can help pave strong relationships with public market investors.
Private Investment Outlook
In our private market outlook collection, we explore the themes driving the rapid evolution of private credit and private equity markets.
Venture capital outlook for 2025: 5 key trends
Our venture capital experts are encouraged by the healthier environment for venture capital in 2025. In this year's outlook, they explore key themes for the year ahead, including: higher deployment, AI, rebounding IPOs, and impacts of the 2024 election.
AI is hungry: What’s on the menu?
Our technology venture capital experts explore AI’s potential for disruption, highlight potential winners and losers, and dive deep into the innovation’s impact on the software industry.
Measuring impact in venture capital
We highlight why venture capital matters to impact investors and how to authentically measure and manage impact in this asset class.
Decoding impact expectations: best practices for impact investors and companies
We share three recommendations each for impact investors and companies to help them better understand and manage each other's expectations.
Designing an executive compensation program: Five best practices for private companies
Our Value Creation Team highlights best practices for creating effective executive compensation programs for private companies approaching IPO.
Private equity deep dive
We explore four key private equity questions to help investors better understand how these strategies compare and complement each other in a portfolio. In particular, we highlight the distinct opportunity sets, risk-return characteristics, and portfolio roles of venture capital and buyout strategies.
CLO equity insights: Private credit
Explore how the convergence of public and private markets is impacting CLO equity, including the unexpected benefit it has driven in recent years.
Human capital management for private companies
We discuss why effective people management is critical for private companies and outline four strategic focus areas that can help companies navigate evolving employee needs, regulatory changes, and investor expectations.
Biotech IPOs in 2025: Quantity, quality, and best practices
We explore today's biotech IPO market, highlighting recent market trends, key characteristics for successful biotech IPOs, and best practices to sustain momentum as a public biotechnology company.
URL References
Related Insights
More private investing focus areas
Venture capital
We seek out companies at the nexus of scientific breakthroughs and medical needs with innovations that are improving the standard of care of medicine for patients.
To guide late-stage private companies through the finish line and beyond, we leverage our deep industry expertise, resources, and long-term relationships across public and private markets.
Private credit
This reflects substantially all portfolio company investments made by Wellington Management’s dedicated private equity portfolios. Due to confidentiality restrictions, some company names cannot be disclosed. Additional information is available upon request. As of 31 October 2024.
